# Glasir Medical, LP – FDA Inspection, Feb 29, 2012

Source: https://www.keypedia.com/records/fda_inspections/glasir-medical-lp/7041f7e4-de00-4b10-a01e-10b0f7734536
Source feed: FDA_Inspections

> FDA inspection 769845 of Glasir Medical, LP, February 29, 2012. Classification: Voluntary Action Indicated (VAI). 4 citations under 21 CFR part 1271. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 769845
- Company Name: Glasir Medical, LP
- Inspection Date: 2012-02-29
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 4

## Related Documents

- [FDA Inspection 1016248 - 2017-06-28](https://www.keypedia.com/records/fda_inspections/glasir-medical-lp/ad73c6ad-a226-44ce-8f5c-6ff43ba1a946)
- [FDA Inspection 821991 - 2013-03-20](https://www.keypedia.com/records/fda_inspections/glasir-medical-lp/9c886cc9-09c5-4e86-948b-8eaa5d241b57)

Company: https://www.keypedia.com/companies/glasir-medical-lp/c85030d0-5bed-437c-9de2-d32da9d6552e

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d